Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

209.40
-1.7200-0.81%
Post-market: 208.50-0.9000-0.43%19:59 EDT
Volume:5.65M
Turnover:1.19B
Market Cap:370.09B
PE:88.73
High:213.49
Open:211.42
Low:209.12
Close:211.12
52wk High:244.81
52wk Low:164.39
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.53
T/O Rate:0.32%
Dividend:6.65
Dividend Rate:3.18%
EPS(TTM):2.36
EPS(LYR):2.36
ROE:6225.00%
ROA:9.81%
PB:-113.18
PE(LYR):88.73

Loading ...

Scotiabank Reaffirms Their Buy Rating on AbbVie (ABBV)

TIPRANKS
·
Mar 10

Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors

TIPRANKS
·
Mar 10

BRIEF-Abbvie Says CEO Robert Michael's 2025 Total Compensation Was $32.5 Million - SEC Filing

Reuters
·
Mar 10

AbbVie Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 10

AbbVie's Study of Weight-Loss Drug Outperforms Placebo

MT Newswires Live
·
Mar 09

Gubra's Partner Abbvie Reports Positive Phase 1 Results For ABBV-295

Reuters
·
Mar 09

Abbvie Announces Positive Topline Results From a Phase 1 Multiple Ascending Dose Study of Abbv-295, a Long-Acting Amylin Analog, in Adults

THOMSON REUTERS
·
Mar 09

Abbvie - Abbv-295 Shows Body Weight Reduction of up to -9.79% at Week 12, -9.73% at Week 13

THOMSON REUTERS
·
Mar 09

Abbvie - Abbv-295 Demonstrates Favorable Tolerability Profile With No Serious Adverse Events

THOMSON REUTERS
·
Mar 09

Exxon, AbbVie, Chevron, Home Depot, Rivian Insider Shock

TIPRANKS
·
Mar 07

AbbVie SVP and Controller David Ryan Purdue Disposes of Common Shares

Reuters
·
Mar 07

AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Mar 06

Evercore ISI Adjusts AbbVie Price Target to $233 From $228, Maintains Outperform Rating

MT Newswires Live
·
Mar 05

Regenxbio Q4 R&D expenses rise 18.3% to USD 59.6 million

Reuters
·
Mar 05

J.P. Morgan Sticks to Its Buy Rating for AbbVie (ABBV)

TIPRANKS
·
Mar 05

AbbVie completes $8B senior notes offering

Reuters
·
Mar 05

AbbVie Advances Venetoclax Into Rare Blood Cancers With New Phase 2 Study

TIPRANKS
·
Mar 05

BRIEF-Allergan Aesthetics Highlights Medical Weight Loss (Mwl) Data And The Changing Profile Of Patients

Reuters
·
Mar 04

AbbVie’s Allergan Aesthetics spotlights new medical weight loss data showing rising demand for facial volume restoration

Reuters
·
Mar 04

Allergan Aesthetics Highlights Medical Weight Loss (Mwl) Data and the Changing Profile of Patients

THOMSON REUTERS
·
Mar 04